Amin Khan

Amin Khan

Company: Afrigen Biologics

Job title: Chief Science , World Health Organization & Messenger Ribonucleic acid Program Advisor

Seminars:

Towards Global Access & Equity for mRNA Technology: An Update from Afrigen Biologics 11:00 am

Unlocking mRNA vaccine design, development and production geared to enable LMICs to produce mRNA products Establishing a “green fields” mRNA end to end commercial production process Product innovations for effective, affordable and accessible mRNA vaccines for neglected diseases suitable for LMICs and relevance to pandemic preparednessRead more

day: Day 2 Track 2 AM

Fireside Discussion: mRNA Pandemic Preparedness – Ensuring Speed, Manufacturability & Supply of mRNA Drugs With Coordinated Global Efforts to Ensure Benefit for All 1:30 pm

What is required to ensure mRNA vaccine development at speed with a coordinated effort?  How to accelerate mRNA vaccine process manufacturing to combat future pandemics? How can we apply learnings to promote global access to mRNA technology that will be key for pandemic preparedness?Read more

day: Day 2 Track 2 PM

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.